Reportstack

Biofrontera AG - Product Pipeline Review - 2012 New Report

 

Naperville, IL -- (ReleaseWire) -- 09/24/2012 -- Biofrontera AG - Product Pipeline Review - 2012 provides data on the Biofrontera AG’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- Biofrontera AG - Brief Biofrontera AG overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Biofrontera AG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Biofrontera AG with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Biofrontera AG’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Biofrontera AG’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Biofrontera AG in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Biofrontera AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Biofrontera AG.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Biofrontera AG and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Biofrontera AG; Biofrontera AG - Key Therapeutics; Biofrontera AG - Pipeline Overview and Promising Molecules; Biofrontera AG - News; Biofrontera AG - Latest Updates; Biofrontera AG - Pipeline; Biofrontera AG - Discontinued/Dormant Projects

To view table of contents for this market report please visit:
http://www.reportstack.com/product/89962/biofrontera-ag-product-pipeline-review-2012.html